Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group2024-08-202024-08-202024-03RECOVERY Collaborative Group 2024, 'Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial', The Lancet Child and Adolescent Health, vol. 8, no. 3, pp. 190-200. https://doi.org/10.1016/S2352-4642(23)00316-42352-4642ORCID: /0000-0003-1556-0097/work/166227094https://hdl.handle.net/2164/2407811566236engR MedicineSupplementary Informationhttps://ars.els-cdn.com/content/image/1-s2.0-S2352464223003164-mmc1.pdfRImmunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trialJournal article10.1016/S2352-4642(23)00316-483